RFK Jr vow to purge FDA sets up collision with Big Pharma
Any changes Robert F. Kennedy Jr. wants to make will come up against a pharmaceutical industry that pays much of the U.S.
Analysis-RFK Jr Vow to Purge FDA Sets up Collision With Big Pharma
WASHINGTON/NEW YORK (Reuters) - Robert F. Kennedy Jr. vowed to purge the U.S. Food and Drug Administration shortly before ...
RFK Jr. Promotes Raw Milk—What Does the FDA Say?
Donald Trump's pick for secretary of the Department of Health and Human Services is a fan of raw milk, despite the FDA saying ...
McDonald's Onion Recall Update as FDA Sets Highest Risk Level
The FDA has issued a Class I risk classification for a large number of recalled onions produced by Taylor Farms.
US FDA approves Syndax's blood cancer drug
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
Is the FDA contributing to the homelessness crisis?
The FDA’s REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial ...
MedPage Today2d
Clozapine's REMS Program on the Chopping Block at Upcoming FDA Meeting
"Severe neutropenia occurs in a small percentage of patients taking clozapine; however, neutropenia is associated with an ...
Even if RFK Jr. fires everyone at the FDA, if won’t matter because he doesn’t know anyone with the ‘technical expertise’ to alter the rules, former chief counsel says
Donald Trump has tapped vaccine-skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
New FDA rules for TV drug ads: Simpler language and no distractions
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...
FDA vaccines chief hopes for common ground with RFK Jr.
The FDA's Dr. Peter Marks says he hopes to keep his job under a second Trump term, and urges Robert F. Kennedy Jr. to "keep ...
FDA Grants Breakthrough Therapy Designation to Huahui Health's Libevitug (HH-003) for treatment of chronic Hepatitis D virus infection
Huahui Health, a clinical-stage biotechnology company focused on discovering and developing novel therapies in the areas of viral hepatitis, hepatology, and oncology, today announced that its ...